MICHAEL FELD: Open Payments
NPI 1427057322 · NORTHBROOK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$134,374 in 227 payments from 9 companies in 2025. Trend: 2023 $337,110 · 2024 $125,597 · 2025 $134,374
Honoraria: $99,775Travel & lodging: $16,332Speaker / faculty: $14,300Food & beverage: $3,717Consulting: $250
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 96 | $64,551 |
| Tris Pharma Inc | 81 | $53,746 |
| AYTU BioPharma, Inc. | 8 | $9,687 |
| Neos Therapeutics, LP | 17 | $5,977 |
| Corium, LLC | 9 | $184 |
| Lundbeck LLC | 11 | $150 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: Qelbree, Dyanavel XR, Adzenys XR-ODT, Cotempla XR-ODT, Azstarys, REXULTI, Auvelity, COBENFY.
Industry payments across IL — which companies pay providers there.
